Ushbu ish iqtibos qilgan ishlar

114 ta ish

Ish: Leveraging Chimeric Antigen Receptor-T Cell Therapy for the Treatment of Multiple Sclerosis: Bridging Oncology and Neurology

1. The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials

   Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi

   Sharh maqola20237 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.475907

2. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

   Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi +2

   Sharh maqola20247 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.475925

3. CAR-T cell therapy for cancer: current challenges and future directions

   Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7

   Sharh maqola20257 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.830985

4. CAR-T cell therapy: current limitations and potential strategies

   Robert C. Sterner, Rosalie M. Sterner

   Sharh maqola20215 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.102886

5. Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors

   Elnaz Khodabandehloo, Mohammad Rayati, Ehsan Ahmadi +3

   Maqola20255 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.854910

6. Sarlavhasiz

   Boshqa4 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.431526

7. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

   Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman +4

   Sharh maqola20244 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.475949

8. Sarlavhasiz

   Boshqa4 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.830238

9. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   MaqolaCAR-T cell therapy researchClinical & Translational Oncology20263 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.000172

10. Sarlavhasiz

    Boshqa3 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.418270

11. Sarlavhasiz

    Boshqa3 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.711570

12. Sarlavhasiz

    Boshqa3 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.936996

13. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.289796

14. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.340843

15. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.340852

16. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.340870

17. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.418207

18. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.431215

19. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.475809

20. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.475856

21. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.475893

22. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.475938

23. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.475945

24. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.839636

25. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.872742